Material Agreement Form 8 K

Item 1.01Entry into a Material Definitive Agreement

Extension of Master Loan and Security Agreement

On July 29, 2024, IGC Pharma, Inc. ("IGC" or the "Company") entered into an amendment to extend its existing Master Loan and Security Agreement along with the General Banking Facility Letter (collectively called the "Loan Agreement") with O-Bank, CO., LTD., a banking corporation incorporated under the laws of Taiwan, as administrative agent and lender (the "Lender'), effective July 8, 2024. The amendment extends the term of the Loan Agreement, which was set to expire, under the same terms and conditions as previously disclosed on the Company's Current Report on Form 8-K filed with the Securities Exchange Commission on July 7, 2023, with the exception of a reduction in the facility fees from $120,000 to $84,000. All other material terms of the Loan Agreement remain unchanged.

The foregoing summary of the Loan Agreement is qualified in its entirety by reference to the full text of the Loan Agreement, a copy of which is filed hereto as Exhibit 10.1 to this Current Report on Form 8-K and incorporated by reference herein.